Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:14610651rdf:typepubmed:Citationlld:pubmed
pubmed-article:14610651lifeskim:mentionsumls-concept:C0012634lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0001479lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C1521991lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C1550605lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0456205lld:lifeskim
pubmed-article:14610651lifeskim:mentionsumls-concept:C0556150lld:lifeskim
pubmed-article:14610651pubmed:issue11lld:pubmed
pubmed-article:14610651pubmed:dateCreated2003-11-11lld:pubmed
pubmed-article:14610651pubmed:abstractTextThe omega-3 polyunsaturate, docosahexaenoic acid (DHA), plays a number of biologically important roles, particularly in the nervous system, where it is found in very high concentrations in cell membranes. In infants DHA is required for the growth and functional development of the brain, with a deficiency resulting in a variety of learning and cognitive disorders. During adulthood DHA maintains normal brain function and recent evidence suggests that reduced DHA intake in adults is linked with a number of neurological disorders including schizophrenia and depression. Here we report a high positive correlation between the molecular activity (ATP min(-1)) of individual Na(+)K(+)ATPase units and the content of DHA in the surrounding membrane bilayer. This represents a fundamental relationship underlying metabolic activity, but may also represent a link between reduced levels of DHA and neurological dysfunction, as up to 60% of energy consumption in the brain is linked to the Na(+)K(+)ATPase enzyme.lld:pubmed
pubmed-article:14610651pubmed:languageenglld:pubmed
pubmed-article:14610651pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14610651pubmed:citationSubsetIMlld:pubmed
pubmed-article:14610651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14610651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14610651pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:14610651pubmed:statusMEDLINElld:pubmed
pubmed-article:14610651pubmed:monthNovlld:pubmed
pubmed-article:14610651pubmed:issn0028-1042lld:pubmed
pubmed-article:14610651pubmed:authorpubmed-author:HulbertA JAJlld:pubmed
pubmed-article:14610651pubmed:authorpubmed-author:ElsePaul LPLlld:pubmed
pubmed-article:14610651pubmed:authorpubmed-author:TurnerNigelNlld:pubmed
pubmed-article:14610651pubmed:issnTypePrintlld:pubmed
pubmed-article:14610651pubmed:volume90lld:pubmed
pubmed-article:14610651pubmed:ownerNLMlld:pubmed
pubmed-article:14610651pubmed:authorsCompleteYlld:pubmed
pubmed-article:14610651pubmed:pagination521-3lld:pubmed
pubmed-article:14610651pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:meshHeadingpubmed-meshheading:14610651...lld:pubmed
pubmed-article:14610651pubmed:year2003lld:pubmed
pubmed-article:14610651pubmed:articleTitleDocosahexaenoic acid (DHA) content of membranes determines molecular activity of the sodium pump: implications for disease states and metabolism.lld:pubmed
pubmed-article:14610651pubmed:affiliationMetabolic Research Centre, University of Wollongong, 2522, Wollongong, NSW, Australia.lld:pubmed
pubmed-article:14610651pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:14610651pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14610651lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:14610651lld:pubmed